scholarly journals Salivary Heparanase Level Is a Potential Biomarker to Diagnose and Prognose the Malignant Salivary Gland Tumor

PLoS ONE ◽  
2015 ◽  
Vol 10 (11) ◽  
pp. e0143009 ◽  
Author(s):  
Xiangbing Wu ◽  
Jun Yu ◽  
Guilin Gao ◽  
Xin Wang ◽  
Yang Liu ◽  
...  
1976 ◽  
Vol 102 (11) ◽  
pp. 699 ◽  
Author(s):  
Dale H. Rice ◽  
John G. Batsakis ◽  
Kenneth D. McClatchey

2006 ◽  
Vol 132 (3) ◽  
pp. 724-725
Author(s):  
Sotirios Papafragkou ◽  
Ludmila Haimovici ◽  
Stewart Fox ◽  
Debasis Adhikari ◽  
Peter Chak ◽  
...  

2013 ◽  
Vol 5 (4) ◽  
pp. 1363-1369 ◽  
Author(s):  
GUILAN WANG ◽  
XIAOLIN GU ◽  
LI CHEN ◽  
YINMEI WANG ◽  
BIN CAO ◽  
...  

2015 ◽  
Vol 5 (1) ◽  
pp. 31-34
Author(s):  
Kartik Poonja ◽  
Janaki Subramanian Iyer ◽  
Leela Poonja

ABSTRACT Mucoepidermoid carcinoma (MEC) is the most common malignant salivary gland tumor, comprising about 15% of all salivary gland tumors and 30% of all salivary malignancies. Most of the MEC arise in the parotid gland. Rarely, it originates in the mandible and maxilla as an intraosseous variant, referred to as ‘central mucoepidermoid carcinoma’ or ‘intraosseous mucoepidermoid carcinoma’. Central mucoepidermoid carcinomas (CMECs) are extremely rare, but well-known entity, comprising 2 to 3% of all MECs reported. Histopathologically, this malignant neoplasm is characterized by mucous, intermediate and epidermoid cells. In this report, we present a case of a male patient diagnosed as low grade CMEC. How to cite this article Iyer JS, Poonja K, Pathak J, Patel S, Poonja L. Low Grade Central Mucoepidermoid Carcinoma. J Contemp Dent 2015;5(1):31-34.


2019 ◽  
Vol 15 (3) ◽  
pp. 202-205
Author(s):  
Rajina Sahi ◽  
Dilip Karmacharya ◽  
Dej Kumar Gautam ◽  
Anil Bikram Karki ◽  
Amar Shrestha

Background: Salivary gland tumors represent a different variety of histological types. The definite diagnosis of type of salivary gland tumor is required for proper treatment planning. The aim of this study was to evaluate the pattern of salivary gland malignancy in B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan. Methods: This cross-sectional study was carried out in patients of malignant salivary gland tumor registered in B.P. Koirala Memorial Cancer hospital retrospectively from September 2009 to August 2012. Results: Parotid gland was the most common sites for malignant salivary gland tumor (80%) followed by submandibular gland (20%). Mucoepidermoid carcinoma is the most common malignant salivary gland tumor of parotid gland and Adenoid cystic carcinoma was the most common malignant tumor of submandibu-lar gland. Male: Female ratio was 1.5:1 with age range from 12 years to 71 years. Common age group for malignant salivary gland tumor was from 50 to 60 years. Conclusions: Parotid was the most common site whereas Mucoepidermoid carcinoma was the most common malignant tumor of major salivary gland.


Sign in / Sign up

Export Citation Format

Share Document